September 2022

About Authors
Avdesh Thassu
MPharm (Nat. Chem.); MBA(Mkt.)
Associate Vice President
Global Regulatory Affairs,
Emami Limited,
7044455199
athassu@hotmail.com

Chandra Mohan Nandi
MSc. (Organic Chem.)
Deputy Manager,
Global Regulatory Affairs,
Emami Limited,
9051706947
chandramohannandi@yahoo.in

Vinay Kumar Singh.  
Head-Formulation
Kumar Organic Products Research Centre Pvt. Ltd.,
Bengaluru
Email : formulation_krc@kopresearchcentre.net

AbbVies mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.

Post : Clinical Specialist

Applications are invited form eligible candidates to fill up the vacant post under NHM, Kandhamal. The eligibility criteria, Term & conditions, vacancy, monthly remuneration & Application Form for the vacant post can be downloaded from district web site.

Post : Pharmacist - MHU

Al-Ameen College of Pharmacy, Bangalore is established under the aegis of Al-Ameen Educational Society in 1983, the College has been a nurturing ground for pharmaceutical professionals. In keeping with its objective of providing the best possible pharmaceutical education, the College has built up a strong infrastructure. This comprises of highly knowledgeable faculty, most of whom hold doctorates and facilities that enable students to gain a contemporary education.

National Agri-Food Biotechnology Institute (NABI) is an autonomous Institute under the Department of Biotechnology, Government of India. NABI aims at catalyzing the transformation of the Agri-food sector in India by being a nodal organization for knowledge generation and translational science leading to value-added products based on Agri-Food biotech innovations for improved household nutritional security.

Novartis announced it is investing in next-generation biotherapeutics with the creation of a fully integrated, dedicated USD 300m scientific environment that will bolster its capacity and capabilities for early technical development of biologics. Spanning both drug substance and drug product development, the multi-year investment will be implemented across existing Novartis locations in Switzerland, Slovenia and Austria, strengthening Novartis ability to deliver on the increasing growth and diversity of its early-stage biotherapeutics portfolio.

Tumor cells are notoriously good at evading the human immune system; they put up physical walls, wear disguises and handcuff the immune system with molecular tricks. Now, UC San Francisco researchers have developed a drug that overcomes some of these barriers, marking cancer cells for destruction by the immune system.

A pathogenic fungus undergoes a remarkable transformation once it enters the body, allowing it to infect the brain, according to new research by scientists at University of Utah Health. Studies in mice show that as the fungal intruder travels to different organs, it changes in size and acquires characteristics that help infection to spread, all in a matter of days.